Clinical Trial Update: Depo-Medroxyprogesterone Acetate (DMPA, Depo-Provera) Use With Certain Anti-HIV Drugs in HIV-Infected Women [NA]

View source ↗

Summary

A completed clinical trial evaluated how Depo-Provera (medroxyprogesterone acetate) interacts with certain antiretroviral drugs in HIV-infected women.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Certain antiretroviral drugs (antiretroviral drugs)
• Depo-Provera (medroxyprogesterone acetate)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | NA | Status: COMPLETED